ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity

Carcinogenesis. 2009 May;30(5):737-44. doi: 10.1093/carcin/bgp034. Epub 2009 Jan 28.


Ion channels are found in a variety of cancer cells and necessary for cell cycle and cell proliferation. The roles of K(+) channels in the process are, however, poorly understood. In the present study, we report that adenosine triphosphate (ATP)-sensitive potassium channel activity plays a critical role in the proliferation of glioma cells. The expression of K(ATP) channels in glioma tissues was greatly increased than that in normal tissues. Treatment of glioma cells with tolbutamide, K(ATP) channels inhibitor, suppressed the proliferation of glioma cells and blocked glioma cell cycle in G(0)/G(1) phase. Similarly, downregulation of K(ATP) channels by small interfering RNA (siRNA) inhibited glioma cell proliferation. On the other hand, K(ATP) channels agonist diazoxide and overexpression of K(ATP) channels promoted the proliferation of glioma cells. Moreover, inhibiting K(ATP) channels slowed the formation of tumor in nude mice generated by injection of glioma cells. Whereas activating K(ATP) channels promoted development of tumor in vivo. The effect of K(ATP) channels activity on glioma cells proliferation is mediated by extracellular signal-regulated kinase (ERK) activation. We found that activating K(ATP) channel triggered ERK activation and inhibiting K(ATP) channel depressed ERK activation. U-0126, the mitogen-activated protein kinase kinase (MAPK kinase) inhibitors blocked ERK activation and cell proliferation induced by diazoxide. Furthermore, constitutively activated MEK plasmids transfection reversed the inhibitory effects of tolbutamide on glioma proliferation, lending further support for a role of ERK in mediating this process. Our results suggest that K(ATP) channels control glioma cell proliferation via regulating ERK pathway. We concluded that K(ATP) channels are important in pathological cell proliferation and open a promising pathway for novel targeted therapies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biopsy
  • Cell Cycle / physiology
  • Cell Division
  • Cell Line, Tumor
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Glioma / enzymology
  • Glioma / genetics
  • Glioma / pathology*
  • Homeostasis
  • Humans
  • Immunohistochemistry
  • KATP Channels / genetics
  • KATP Channels / physiology*
  • Mice
  • Mice, Nude
  • Mitogen-Activated Protein Kinases / metabolism*
  • Potassium Channels, Inwardly Rectifying / genetics
  • RNA, Small Interfering / genetics
  • Transfection


  • KATP Channels
  • Kir6.2 channel
  • Potassium Channels, Inwardly Rectifying
  • RNA, Small Interfering
  • Extracellular Signal-Regulated MAP Kinases
  • Mitogen-Activated Protein Kinases